To date, dietary interventions for depression provide the strongest experimental evidence for the role of nutrition in mental health. In the Food & Mood Centre’s SMILES trial (Supporting the Modification of Lifestyle in Lowered Emotional States), adults with moderate to severe major depressive disorder who received nutritional counseling for 12 weeks had more improvement in symptoms and a greater likelihood of remission than adults in the control group, who received a social support protocol following the same schedule as the nutritional counseling (Jacka, F. N., et al., BMC Medicine, Vol. 15, No. 23, 2017opens in new window). Meta-analyses of randomized controlled trials and cross-sectional studies indicate that following a Mediterranean or similar diet reduces depressive symptoms and risk, while diets high in ultra-processed foods increase risk (Bizzozero-Peroni, B., et al., Nutrition Reviews, Vol. 83, No. 1, 2025opens in new window; Firth, J., et al., Biopsychosocial Science and Medicine, Vol. 81, No. 3, 2019opens in new window; Firth, J., et al., World Psychiatry, Vol. 19, No. 3, 2020opens in new window).
Even a simple change—taking daily nutritional supplements—can make a difference. Rucklidge and her colleagues found that adults who took Daily Essential Nutrients from Hardy Nutritionals, a broad-spectrum mix of vitamins and minerals (micronutrients) designed to fill common nutrient gaps, had better improvement in depression and anxiety symptoms than those who took a placebo (Journal of Affective Disorders, Vol. 339, 2023opens in new window).
The same supplements used in that study may reduce mental health risks for pregnant women and improve birth outcomes. In a small trial known as NUTRIMUMopens in new window, Rucklidge found that women with perinatal depression who took the supplements during pregnancy had reduced depression symptoms. Compared with women taking antidepressants, their infants also had a better start to life, including longer gestational age, lower rates of infant resuscitation, and healthier birth lengths (BJPsych Open, Vol. 10, No. 4, 2024opens in new window; Journal of Clinical Psychopharmacology; Vol. 45, No. 1, 2025opens in new window).
“We know that these infant health outcomes can be risk factors for mental health disorders in children,” Rucklidge said. “They seem to have been mitigated with micronutrients, which has never been observed with SSRIs.” (See recent guidelines for micronutrients and mental illness in both adults and children: Sarris, J., et al., The World Journal of Biological Psychiatry, Vol. 23, No. 6, 2022opens in new window; Journal of Child Psychology and Psychiatry, Vol. 66. No. 4, 2025opens in new window).
Broad-spectrum micronutrient supplements might also reduce symptoms of attention-deficit/hyperactivity disorder (ADHD), including hyperactivity, impulsivity, and attention problems (British Journal of Psychology, Vol. 204, No. 4, 2014opens in new window). Research led by clinical psychologist Jeanette Johnstone, PhD, of Oregon Health & Science University, points to the gut microbiome as a pathway for those improvements. Johnstone and her colleagues found that children with ADHD who took daily broad-spectrum micronutrient supplements had changes in fecal bacteria not observed in the placebo group—and that those changes were tied to improvements in ADHD symptoms (Gut Microbes, Vol. 17, No. 1, 2025opens in new window).
Rucklidge has launched a new study to test whether combining nutritional supplements and psychological interventions could offer a synergistic effect for patients. Her team’s Mindfulness and Micronutrients trial explores whether the combination could better help children with emotional dysregulation than either intervention alone.
“The idea is that a well-nourished brain may [improve the effectiveness of] psychotherapy,” Rucklidge said.
In addition to taking supplements and improving overall diet by eating more whole foods, research shows that consuming fermented foods can have a positive impact on the brain—again linked to changes in gut health. In one study from the Food & Mood Centre, healthy women were given either a small daily serving of fermented dairy with probiotic bacteria or a placebo for 8 weeks. Women who consumed fermented dairy had a greater rise in glutathione, the brain’s antioxidant, than those in the control group. They also had increased volume in the hippocampus and greater functional connectivity between the hippocampus and the frontal lobe, which correlated with a rise in fecal probiotic bacteria (publication in press).
Jacka’s team has now developed a digital intervention for improving diet and gut health during pregnancy, which is being tested in a randomized controlled trial of approximately 1,000 mother-child pairs. Outcomes measured will include peri- and postnatal depression; infant well-being, behavior, and neurological development; and several markers of gut health.
Early evidence suggests that metabolic and dietary interventions might also reduce symptoms of serious mental illness. Shebani Sethi, MD, a clinical associate professor and founding director of the Metabolic Psychiatry Clinicopens in new window at Stanford University, pilot tested a 4-month metabolically targeted high-fat, low-carbohydrate (ketogenic) diet intervention to supplement psychiatric care in 21 adults with schizophrenia or bipolar disorder. On average, participants had a 31% improvement on the Clinical Global Impression scale, a standardized tool that gives a snapshot of patient mental health and symptom severity. The trial also reversed metabolic syndrome (a combination of weight, blood sugar, and cholesterol problems) in all participants who had it at baseline, which was associated with an average of 10% body weight loss, and improved several key metabolic markers (Psychiatry Research, Vol. 335, 2024opens in new window).
Sethi is now continuing more research on dietary interventions, including looking at measurements of heart rate variability, exercise, and sleep patterns. The ketogenic diet intervention is intended to complement—not replace—treatment with psychiatric medications, but more controlled research is needed to fully understand its risks and benefits. It may also help reduce metabolic side effects of medications, such as weight gain, high blood pressure, and pre-diabetes, making it easier for patients to continue medications they might otherwise have stopped.
“We really want to improve the quality of life for patients by turning this science into care as quickly as possible,” Sethi said.